• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Medicaid’s Role in Financing Behavioral Health Services for Low-Income Individuals

This issue brief provides an overview of Medicaid’s role in financing behavioral health services. It includes information on eligibility, benefits, service delivery, access to care, and spending. It also discusses the potential impact of Medicaid restructuring as proposed in the Better Care Reconciliation Act.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Medicaid’s Role in Behavioral Health

This infographic highlights Medicaid’s role in facilitating access to behavioral health treatment and the impact of potential reductions in federal Medicaid financing on behavioral health coverage and access to services.

Infographic Read More
The Henry J. Kaiser Family Foundation

Understanding Who Opioid Users Are Underscores Challenges

The 21st Century Cures Act provided a billion dollars in new funding for opioid prevention and treatment. In this Wall Street Journal Think Tank column, Drew Altman looks at the challenges based on a new Kaiser-Washington Post survey of long term opioid users.

Perspective Read More
The Henry J. Kaiser Family Foundation

The Washington Post/Kaiser Survey: 1 in 3 Long-Term Prescription Painkiller Users Think They’re Addicted or Dependent

As the nation struggles with an ongoing epidemic of prescription painkiller abuse, misuse, and overdoses, a new Washington Post/Kaiser Family Foundation survey finds that one in three (34%) of those who recently used such drugs for at least two months report being addicted or dependent. Featured in Sunday’s The Washington…

News Release Read More
The Henry J. Kaiser Family Foundation

The Washington Post/Kaiser Family Foundation Survey of Long-Term Prescription Painkiller Users and Their Household Members

This partnership poll from The Washington Post and the Kaiser Family Foundation examines the long-term use of prescription painkillers by exploring the views and experiences of adults 18 and over who they themselves, or a household member, have taken strong prescription painkillers for a period of two months or more at some time in the past two years, other than to treat pain from cancer or terminal illness. The survey takes a closer look at long-term users of prescription painkillers to better understand how they started taking these drugs, their interactions with medical providers, their concerns and experiences with addiction, and their views of efforts to stem the abuse of painkillers.

Report Read More
The Henry J. Kaiser Family Foundation

Where President-elect Donald Trump Stands on Six Health Care Issues

Where does President-elect Donald Trump stand on key health care issues? This snapshot outlines his positions and policy statements during the campaign on issues such as health insurance, the ACA, Medicaid, Medicare, the opioid epidemic, prescription drug costs, and women’s reproductive health.

Issue Brief Read More

Snapshot of Where Hillary Clinton and Donald Trump Stand on Seven Health Care Issues

Where do the 2016 Presidential candidates, Hillary Clinton and Donald Trump, stand on key health care issues? This snapshot outlines the candidates’ positions and policy statements on issues such as health insurance, the ACA, Medicaid, Medicare, the opioid epidemic, prescription drug costs, women’s reproductive health, and Zika.

Issue Brief Read More

Medicaid’s Most Costly Outpatient Drugs

Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Analysis Finds Specialty Drugs Rank High Among Medicaid’s Most Costly Outpatient Drugs

Costly specialty drugs, such as those used to treat Hepatitis C and HIV, are among the most costly medications in state Medicaid programs, chiefly because of their high prices for a course of treatment, according to a new Kaiser Family Foundation analysis of Medicaid’s most costly outpatient drugs. Abilify, an…

News Release Read More